- $166.65m
- $164.15m
- $31.32m
- 76
- 15
- 90
- 62
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.8 | 20.5 | 24.5 | 29.9 | 31.3 |
Cost of Revenue | |||||
Gross Profit | 6.36 | 14.5 | 18.4 | 22.7 | 24.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.6 | 27.6 | 38.7 | 40.3 | 37.3 |
Operating Profit | -7.82 | -7.13 | -14.2 | -10.4 | -5.96 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.78 | -7.16 | -14.2 | -10.4 | -5.87 |
Net Income After Taxes | -7.78 | -7.16 | -14.2 | -10.4 | -5.87 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.78 | -7.16 | -14.2 | -10.4 | -5.87 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.83 | -7.21 | -14.3 | -10.4 | -5.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.966 | -0.774 | -1.22 | -0.695 | -0.423 |